Members Only Content
Subscribe to get full access
Free Preview
The advanced imaging company hopes to kick-off its ambitious commercialization plans this year, but the FDA has been pumping the brakes.
Upstart Recommendation Report Upstart Presentation Slides
Lemonade (NYSE: LMND) is a new player who's really adding zest to the insurance industry. Its AI-powered underwriting enables it to [...]
PubMatic just reported first quarter 2025 results. Aside from the headwinds of a DSP partner changing its bidding process, the [...]
